我们的社会欢迎对里程碑式试验RENAAL进行日本亚组分析。 - Suppr

Suppr

超能文献

Japanese subpopulation analysis of the RENAAL, the landmark trial, is welcomed by our society.

作者信息

Kimura Genjiro

出版信息

Clin Exp Nephrol. 2006 Sep;10(3):226-7. doi: 10.1007/s10157-006-0430-y.

DOI:10.1007/s10157-006-0430-y

PMID:17009082

Abstract

摘要

相似文献

Japanese subpopulation analysis of the RENAAL, the landmark trial, is welcomed by our society.我们的社会欢迎对里程碑式试验RENAAL进行日本亚组分析。

Clin Exp Nephrol. 2006 Sep;10(3):226-7. doi: 10.1007/s10157-006-0430-y.

Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes: a subanalysis of Japanese patients from the RENAAL study.2型糖尿病患者的肾素-血管紧张素-醛固酮系统阻断与肾脏疾病：RENAAL研究中日本患者的亚组分析

Clin Exp Nephrol. 2006 Sep;10(3):193-200. doi: 10.1007/s10157-006-0427-6.

Losartan in diabetic nephropathy.氯沙坦与糖尿病肾病

Expert Rev Cardiovasc Ther. 2004 Jul;2(4):473-83. doi: 10.1586/14779072.2.4.473.

Losartan: lessons learned from the RENAAL study.氯沙坦：从RENAAL研究中获得的经验教训。

Expert Opin Pharmacother. 2006 Apr;7(5):623-30. doi: 10.1517/14656566.7.5.623.

Efficacy and safety of angiotensin II receptor blockade in elderly patients with diabetes.血管紧张素II受体阻滞剂在老年糖尿病患者中的疗效与安全性

Diabetes Care. 2006 Oct;29(10):2210-7. doi: 10.2337/dc06-0570.

Renin angiotensin system blockade and nephropathy: why is it being called into question, and should it be?肾素-血管紧张素系统阻断与肾病：为何受到质疑，是否应受质疑？

Clin J Am Soc Nephrol. 2006 Sep;1(5):1046-8. doi: 10.2215/CJN.00540206. Epub 2006 Jul 19.

Losartan in patients with type 2 diabetes and proteinuria: observations from the RENAAL Study.氯沙坦用于2型糖尿病合并蛋白尿患者：RENAAL研究的观察结果

Kidney Int Suppl. 2002 Dec(82):S64-7. doi: 10.1046/j.1523-1755.62.s82.13.x.

The effect of losartan on hemoglobin concentration and renal outcome in diabetic nephropathy of type 2 diabetes.氯沙坦对2型糖尿病糖尿病肾病患者血红蛋白浓度及肾脏结局的影响。

Kidney Int. 2008 Mar;73(5):630-6. doi: 10.1038/sj.ki.5002746. Epub 2007 Dec 19.

Aliskiren and dual therapy in type 2 diabetes mellitus.阿利吉仑与2型糖尿病的联合治疗

N Engl J Med. 2008 Jun 5;358(23):2503-5. doi: 10.1056/NEJMe0803375.

Losartan reduces the burden and cost of ESRD: public health implications from the RENAAL study for the European Union.氯沙坦降低终末期肾病的负担和成本：RENAAL研究对欧盟的公共卫生影响

Kidney Int Suppl. 2002 Dec(82):S68-72. doi: 10.1046/j.1523-1755.62.s82.14.x.

本文引用的文献

Clin Exp Nephrol. 2006 Sep;10(3):193-200. doi: 10.1007/s10157-006-0427-6.

Proposal for mapping renal failure in Japan and its application for strategy to arrest endstage renal disease.日本肾衰竭情况测绘方案及其在阻止终末期肾病策略中的应用

Clin Exp Nephrol. 2006 Mar;10(1):8-12. doi: 10.1007/s10157-005-0404-5.

Remodeling of renal interstitial and tubular lesions in pancreas transplant recipients.胰腺移植受者肾间质和肾小管病变的重塑

Kidney Int. 2006 Mar;69(5):907-12. doi: 10.1038/sj.ki.5000153.

Factors associated with frequent remission of microalbuminuria in patients with type 2 diabetes.2型糖尿病患者微量白蛋白尿频繁缓解的相关因素。

Diabetes. 2005 Oct;54(10):2983-7. doi: 10.2337/diabetes.54.10.2983.

Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria.2型糖尿病合并微量白蛋白尿患者在多因素治疗期间实现向正常白蛋白尿的缓解可保护肾功能。

Nephrol Dial Transplant. 2004 Nov;19(11):2784-8. doi: 10.1093/ndt/gfh470. Epub 2004 Aug 24.

Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.蛋白尿，2型糖尿病肾病患者肾脏保护的一个靶点：来自RENAAL研究的经验教训

Kidney Int. 2004 Jun;65(6):2309-20. doi: 10.1111/j.1523-1755.2004.00653.x.

Retarding the progression of renal disease.延缓肾脏疾病的进展。

Kidney Int. 2003 Jul;64(1):370-8. doi: 10.1046/j.1523-1755.2003.t01-2-00052.x.

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.2型糖尿病患者的多因素干预与心血管疾病

N Engl J Med. 2003 Jan 30;348(5):383-93. doi: 10.1056/NEJMoa021778.

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.氯沙坦对2型糖尿病肾病患者肾脏和心血管结局的影响。

N Engl J Med. 2001 Sep 20;345(12):861-9. doi: 10.1056/NEJMoa011161.

Reversal of lesions of diabetic nephropathy after pancreas transplantation.胰腺移植后糖尿病肾病病变的逆转

N Engl J Med. 1998 Jul 9;339(2):69-75. doi: 10.1056/NEJM199807093390202.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验